miRecule, a biotechnology company focusing on RNA therapies, and GBI Biomanufacturing, a CDMO, partnered to advance the development and clinical supply of miRecule’s Antibody-RNA Conjugate (ARC) based ...
Mirecule, Inc., a leader in Antibody RNA Conjugate (ARC) therapeutics targeting rare neuromuscular diseases, today announced an expansion of its strategic collaboration with Sanofi. This collaboration ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. AbbVie is entering a collaboration and license option deal ...
3d
CD Bioparticles Launches Extrahepatic RNA Delivery Services to to Advance Nucleic Acid Therapeutics
CD Bioparticles announces the launch of comprehensive Extrahepatic RNA Delivery services. NEW YORK, NY, UNITED STATES, ...
Preclinical data shows use of megalin receptors for intracellular delivery of a ligand-siRNA conjugate to silence production of target mRNA in the kidney Megalin-binding genetic medicines are ...
PHILADELPHIA--(BUSINESS WIRE)-- Aro Biotherapeutics, a clinical-stage biotechnology company working to develop potent, targeted short-interfering RNA (siRNA) medicines, today announced that its ...
Back in February, I took a detailed look at Avidity Biosciences (RNA), a small-cap biotech developing RNA-based therapies through its Antibody-Oligonucleotide Conjugate (AOC) platform. At that time, I ...
The gold standard for nucleic acid detection uses PCR to amplify the nucleic acid followed by gel electrophoresis or fluorescent label for detection. As such, PCR is not suitable for in situ ...
Choosing the right brain injury rehabilitation program is a critical decision that can shape the future for you or your loved one. Incorporating aquatic therapy can enhance patient outcomes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results